170 related articles for article (PubMed ID: 17620420)
1. In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice.
Jarchum I; Baker JC; Yamada T; Takaki T; Marron MP; Serreze DV; DiLorenzo TP
Diabetes; 2007 Oct; 56(10):2551-60. PubMed ID: 17620420
[TBL] [Abstract][Full Text] [Related]
2. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
[TBL] [Abstract][Full Text] [Related]
3. Immunotargeting of insulin reactive CD8 T cells to prevent diabetes.
Scott GS; Fishman S; Khai Siew L; Margalit A; Chapman S; Chervonsky AV; Wen L; Gross G; Wong FS
J Autoimmun; 2010 Dec; 35(4):390-7. PubMed ID: 20850948
[TBL] [Abstract][Full Text] [Related]
4. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
[TBL] [Abstract][Full Text] [Related]
5. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
6. Developing a novel model system to target insulin-reactive CD8 T cells.
Scott GS; Fishman S; Margalit A; Siew LK; Chapman S; Wen L; Gross G; Wong FS
Ann N Y Acad Sci; 2008 Dec; 1150():54-8. PubMed ID: 19120267
[TBL] [Abstract][Full Text] [Related]
7. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
8. Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes.
Millet I; Wong FS; Gurr W; Wen L; Zawalich W; Green EA; Flavell RA; Sherwin RS
J Autoimmun; 2006 Feb; 26(1):7-15. PubMed ID: 16338119
[TBL] [Abstract][Full Text] [Related]
9. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.
Wong FS; Karttunen J; Dumont C; Wen L; Visintin I; Pilip IM; Shastri N; Pamer EG; Janeway CA
Nat Med; 1999 Sep; 5(9):1026-31. PubMed ID: 10470079
[TBL] [Abstract][Full Text] [Related]
10. Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes.
Ouyang Q; Standifer NE; Qin H; Gottlieb P; Verchere CB; Nepom GT; Tan R; Panagiotopoulos C
Diabetes; 2006 Nov; 55(11):3068-74. PubMed ID: 17065344
[TBL] [Abstract][Full Text] [Related]
11. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
12. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.
de Jersey J; Snelgrove SL; Palmer SE; Teteris SA; Mullbacher A; Miller JF; Slattery RM
Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1295-300. PubMed ID: 17229843
[TBL] [Abstract][Full Text] [Related]
13. CD8+ T lymphocytes specific for glutamic acid decarboxylase 90-98 epitope mediate diabetes in NOD SCID mouse.
Sévère S; Gauvrit A; Vu AT; Bach JM
Mol Immunol; 2007 Apr; 44(11):2950-60. PubMed ID: 17336387
[TBL] [Abstract][Full Text] [Related]
14. Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout.
Jasinski JM; Yu L; Nakayama M; Li MM; Lipes MA; Eisenbarth GS; Liu E
Diabetes; 2006 Jul; 55(7):1978-84. PubMed ID: 16804066
[TBL] [Abstract][Full Text] [Related]
15. HLA class I epitope discovery in type 1 diabetes.
van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
[TBL] [Abstract][Full Text] [Related]
16. Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice.
Hu N; D'Souza C; Cheung H; Lang H; Cheuk E; Chamberlain JW
Vaccine; 2005 Nov; 23(45):5231-44. PubMed ID: 16099553
[TBL] [Abstract][Full Text] [Related]
17. Chlamydia pneumoniae genome sequence analysis and identification of HLA-A2-restricted CD8+ T cell epitopes recognized by infection-primed T cells.
Capo S; Nuti S; Scarselli M; Tavarini S; Montigiani S; Mori E; Finco O; Abrignani S; Grandi G; Bensi G
Vaccine; 2005 Oct; 23(42):5028-37. PubMed ID: 15982792
[TBL] [Abstract][Full Text] [Related]
18. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population.
Amrani A; Verdaguer J; Serra P; Tafuro S; Tan R; Santamaria P
Nature; 2000 Aug; 406(6797):739-42. PubMed ID: 10963600
[TBL] [Abstract][Full Text] [Related]
19. Prevention of "Humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approach.
Niens M; Grier AE; Marron M; Kay TW; Greiner DL; Serreze DV
Diabetes; 2011 Apr; 60(4):1229-36. PubMed ID: 21346176
[TBL] [Abstract][Full Text] [Related]
20. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice.
DiLorenzo TP; Serreze DV
Immunol Rev; 2005 Apr; 204():250-63. PubMed ID: 15790363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
